Welcome to the Amprion 2024 landing page! From here you can download through the links below or explore the rest of our website.

Thank you for joining us at AAN 2024, booth #829
April 13-18, 2024 | Denver, CO

SYNTap Biomarker CSF Test Flyer

Our findings suggest that a sub-group of ALS occurs in which self-replicating α-Syn is detectable and likely contributes to its pathogenesis

“Eur J Neurol, April 2024”

Biomarkers for α-synucleinopathies that reflect underlying pathology are sorely needed to improve the accuracy of early diagnosis and identify subtypes based on molecular factors and thus accelerate clinical trials.

“Movement Disorders, June 2023”

Misfolded α-synuclein (αSyn) aggregates (αSyn-seeds) in cerebrospinal fluid (CSF) are biomarkers for synucleinopathies

“Mov Disord. 2023”

The purpose of this study was to determine the sensitivity and specificity of α-synuclein seed amplification

“Ann Neurol. 2022”

Contact us to schedule a meeting

Please Note: Important Billing Info

To improve patient access to the SYNTap® Biomarker CSF Test, Amprion offers the following billing options:

  • List price of $1500, with courtesy billing for both Medicare and private insurance.
  • An affordable self-pay price of $995 (patients may qualify for financial assistance and/or interest-free payment options).
  • Prices are effective as of January 1, 2024, and are subject to change.

Please note: Amprion is a Medicare participating provider, however, the SYNTap test does not currently have Medicare coverage determination. Also, Amprion is not yet in network with most insurers.

The SYNTap Biomarker CSF Test has been issued a dedicated CPT® PLA code to be used when billing: 0393U.

For additional information, please visit our billing page.